| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid.
|
Gut
|
2005
|
2.13
|
|
2
|
Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples.
|
Clin Chem
|
2000
|
1.85
|
|
3
|
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
|
Hum Mol Genet
|
2001
|
1.81
|
|
4
|
Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses.
|
Endocrinology
|
2003
|
1.63
|
|
5
|
miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.
|
Oncogene
|
2009
|
1.56
|
|
6
|
Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation.
|
Cancer Res
|
1997
|
1.49
|
|
7
|
Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.
|
FEBS Lett
|
2000
|
1.42
|
|
8
|
Bladder squamous cell carcinomas express psoriasin and externalize it to the urine.
|
J Urol
|
1996
|
1.42
|
|
9
|
Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells.
|
Diabetologia
|
2008
|
1.34
|
|
10
|
Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population.
|
Clin Chem
|
1999
|
1.33
|
|
11
|
Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas.
|
Cancer Res
|
1996
|
1.29
|
|
12
|
High-resolution genotyping of Chlamydia trachomatis from recurrent urogenital infections.
|
J Clin Microbiol
|
2000
|
1.28
|
|
13
|
Identification of gene expression patterns in superficial and invasive human bladder cancer.
|
Cancer Res
|
2001
|
1.20
|
|
14
|
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas.
|
Br J Cancer
|
2005
|
1.17
|
|
15
|
A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.
|
Cancer Res
|
2001
|
1.15
|
|
16
|
Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer.
|
Br J Cancer
|
2006
|
1.13
|
|
17
|
Molecular alterations in bladder cancer.
|
Urol Res
|
1998
|
1.09
|
|
18
|
Towards a comprehensive database of proteins from the urine of patients with bladder cancer.
|
J Urol
|
1996
|
1.04
|
|
19
|
Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroups.
|
Br J Cancer
|
2007
|
1.02
|
|
20
|
Gene expression profiling of noninvasive primary urothelial tumours using microarrays.
|
Br J Cancer
|
2005
|
1.01
|
|
21
|
Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways.
|
Diabetologia
|
2004
|
0.98
|
|
22
|
Immunohistochemical demonstration of estrogen receptors (ER) in formalin-fixed, paraffin-embedded human breast cancer tissue by use of a monoclonal antibody to ER.
|
J Histochem Cytochem
|
1988
|
0.97
|
|
23
|
Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.
|
Cancer Res
|
1999
|
0.96
|
|
24
|
Psoriasin (S100A7): a putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas.
|
Electrophoresis
|
1999
|
0.95
|
|
25
|
SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation.
|
Histol Histopathol
|
2008
|
0.95
|
|
26
|
Profiles of Lewisx-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma.
|
Cancer Res
|
1990
|
0.93
|
|
27
|
Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR.
|
Br J Cancer
|
2012
|
0.91
|
|
28
|
Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer.
|
Int J Cancer
|
1998
|
0.90
|
|
29
|
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.
|
Br J Cancer
|
2011
|
0.90
|
|
30
|
A genome-wide search for risk genes using homozygosity mapping and microarrays with 1,494 single-nucleotide polymorphisms in 22 eastern Cuban families with bipolar disorder.
|
Am J Med Genet B Neuropsychiatr Genet
|
2005
|
0.89
|
|
31
|
Efficient mutation detection in mismatch repair genes using a combination of single-strand conformational polymorphism and heteroduplex analysis at a controlled temperature.
|
Genet Test
|
2000
|
0.88
|
|
32
|
A comprehensive protein resource for the study of bladder cancer: http://biobase.dk/cgi-bin/celis.
|
Electrophoresis
|
1999
|
0.88
|
|
33
|
No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
|
Endocr Relat Cancer
|
2007
|
0.87
|
|
34
|
Frequency and mechanism of Lewis antigen expression in human urinary bladder and colon carcinoma patients.
|
Br J Cancer
|
1991
|
0.86
|
|
35
|
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.
|
Oncogene
|
2012
|
0.86
|
|
36
|
The intrauterine metabolic environment modulates the gene expression pattern in fetal rat islets: prevention by maternal taurine supplementation.
|
Diabetologia
|
2008
|
0.85
|
|
37
|
Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia.
|
APMIS
|
2001
|
0.84
|
|
38
|
The C-terminal N-glycosylation sites of the human alpha1,3/4-fucosyltransferase III, -V, and -VI (hFucTIII, -V, adn -VI) are necessary for the expression of full enzyme activity.
|
Glycobiology
|
2000
|
0.83
|
|
39
|
Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression.
|
Cancer
|
1992
|
0.83
|
|
40
|
Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates.
|
Am J Pathol
|
1995
|
0.83
|
|
41
|
Gynecomastia. Immunohistochemical demonstration of estrogen receptors.
|
Acta Pathol Microbiol Immunol Scand A
|
1987
|
0.83
|
|
42
|
ELISA-type titertray assay of IgM anti-GM1 autoantibodies.
|
Clin Chem
|
1994
|
0.83
|
|
43
|
IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course.
|
J Neuroimmunol
|
1997
|
0.82
|
|
44
|
Binding of wheat and peanut lectins to human transitional cell carcinomas. Correlation with histopathologic grade, invasion, and DNA ploidy.
|
Cancer
|
1989
|
0.81
|
|
45
|
Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer.
|
Ann Oncol
|
2014
|
0.79
|
|
46
|
A comparative study of peanut agglutinin and amaranthin binding to human urinary bladder tumor glycoproteins.
|
Scand J Urol Nephrol Suppl
|
1995
|
0.78
|
|
47
|
Increased concentrations of genotype-interpreted Ca 19-9 in urine of bladder cancer patients mark diffuse atypia of the urothelium.
|
Clin Chem
|
1998
|
0.78
|
|
48
|
Blood group ABO and Lewis antigens in fetal and normal adult bladder urothelium: immunohistochemical study of type 1 chain structures.
|
J Urol
|
1987
|
0.78
|
|
49
|
Allelic deletions of cell growth regulators during progression of bladder cancer.
|
Cancer Res
|
2000
|
0.78
|
|
50
|
Squamous cell metaplasia of the bladder urothelium. A retrospective study of 36 patients.
|
APMIS
|
1992
|
0.78
|
|
51
|
Murine monoclonal antibodies directed to the human histo-blood group A transferase (UDP-GalNAc:Fuc alpha 1----2Gal alpha 1----3-N-acetylgalactosaminyltransferase) and the presence therein of N-linked histo-blood group A determinant.
|
Biochemistry
|
1990
|
0.78
|
|
52
|
Expression of histo-blood-group-A/B-gene-defined glycosyltransferases in normal and malignant epithelia: correlation with A/B-carbohydrate expression.
|
Int J Cancer
|
1992
|
0.77
|
|
53
|
Loss of ABH antigen expression in bladder cancer is not caused by loss of heterozygosity of the ABO locus.
|
Int J Cancer
|
1995
|
0.77
|
|
54
|
Lewis antigen expression in benign and malignant tissues from RBC Le(a-b-) cancer patients.
|
Br J Haematol
|
1991
|
0.77
|
|
55
|
Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats.
|
Dig Dis Sci
|
1995
|
0.76
|
|
56
|
Lewis negative phenotype and bladder cancer.
|
Lancet
|
1990
|
0.76
|
|
57
|
Lectinohistochemistry of human bladder cancer: loss of lectin binding structures in invasive carcinomas.
|
APMIS
|
1989
|
0.76
|
|
58
|
DNA replication in experimental rat bladder tumours: immunohistochemical detection of bromodeoxyuridine labelled nuclei.
|
Scand J Urol Nephrol Suppl
|
1989
|
0.76
|
|
59
|
Specificity and immunobiological properties of monoclonal antibody IMH2, established after immunization with Le(b)/Le(a) glycosphingolipid, a novel extended type 1 chain antigen.
|
Cancer Res
|
1992
|
0.76
|
|
60
|
Comparative immunoperoxidase demonstration of T-antigens in human colorectal carcinomas and morphologically abnormal mucosa.
|
Cancer Res
|
1985
|
0.76
|
|
61
|
Immunohistochemistry and cytochemistry of experimental rat bladder cancer: binding of the lectins PNA and WGA and of a Le(Y) mouse monoclonal antibody.
|
J Urol
|
1989
|
0.76
|
|
62
|
Microsatellite alterations in urinary sediments from patients with cystitis and bladder cancer.
|
Int J Cancer
|
2000
|
0.76
|
|
63
|
Glycoproteins in the urothelium and in the urine of the epidermal growth factor induced growing urinary tract in rats.
|
Urol Res
|
1998
|
0.76
|
|
64
|
Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.
|
Cancer Res
|
1992
|
0.76
|
|
65
|
Lewis antigen mediated adhesion of freshly removed human bladder tumors to E-selectin.
|
J Urol
|
1999
|
0.75
|
|
66
|
Blood group ABO-related glycosylation of urothelial cell lines: immunocytological, enzymatic, and genetic characterization.
|
Cancer Res
|
1994
|
0.75
|
|
67
|
A method for T-antigen demonstration by a polyclonal antibody and peanut lectin; elimination of cross-reaction with naturally occurring antibodies.
|
Virchows Arch A Pathol Anat Histopathol
|
1984
|
0.75
|
|
68
|
Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy.
|
Ann Neurol
|
1998
|
0.75
|
|
69
|
Comparison of three methods of microsatellite detection.
|
Scand J Clin Lab Invest
|
1999
|
0.75
|
|
70
|
Lewis blood group antigens in salivary glands and stratified epithelium: lack of regulation of Lewis antigen expression in ductal and buccal mucosal lining epithelia.
|
Vox Sang
|
1991
|
0.75
|
|
71
|
Localization and identification of T-(Gal beta 1-3GalNAc alpha 1-O-R) and T-like antigens in experimental rat bladder cancer.
|
J Urol
|
1992
|
0.75
|